Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid

Journal of Nutrition

Volumn 136, Issue 9, 2006, Pages 2325-2330

  Soriguer, Federico ^a   Morcillo, Sonsoles ^a   Cardona, Fernando ^a   Rojo Martínez, Gemma ^a   Almaráz, María De La Cruz ^a   Ruiz De Adana, María De La Soledad ^a   Olveira, Gabriel ^a   Tinahones, Francisco ^a   Esteva, Isabel ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MONOUNSATURATED FATTY ACID; OLEIC ACID; OLIVE OIL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2;

ADULT; AGED; ALLELE; ANTHROPOMETRY; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POPULATION RESEARCH; SPAIN;

EID: 33748286941     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.9.2325     Document Type: Article

References (45)

1. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev. 1999;20:649-88.
2. Deeb S, Fajas L, Nemoto M, Laakso M, Fujimoto W, Auwerx JA. Pro12Ala substitution in the human peroxisome proliferator-activated receptor gamma2 is associated with decreased receptor activity, improved insulin sensitivity, and lowered body mass index. Nat Genet. 1998;20:284-87.
3. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J, Shuldiner AR. Molecular scanning of the human peroxisome proliferator activated receptor gamma gene in diabetic Caucasians: identification of a Pro12Ala PPARgamma 2 missense mutation. Biochem Biophys Res Commun. 1997;241:270-74.
4. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26:76-80.
5. Frederiksen L, Brodbaek K, Fenger M, Jørgensen T, Borch-Johnsen B, Madsbad S, Urhammer SA. Studies of the Pro12Ala Polymorphism of the PPAR-gamma gene in the Danish MONICA Cohort: Homozygosity of the Ala Allele Confers a Decreased Risk of the Insulin Resistance Syndrome. J Clin Endocrinol Metab. 2002;87:3989-92.
6. Kadowaki T, Hara K, Kubota N, Tobe K, Terauchi Y, Yamauchi T, Eto K, Kadowaki H, Noda M, et al. The role of PPAR gamma in high-fat diet-induced obesity and insulin resistance. J Diabetes Complications. 2002;16:41-5.
7. Gonzalez Sanchez JL, Serrano Rios M, Fernandez Perez C, Laakso M, Martinez Larrad MT. Effect of the Pro12Ala polymorphism of the peroxisome proliferatoractivated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur J Endocrinol. 2002;147:495-501.
8. Miles PDG, Barak Y, He W, Evans RM, Olefsky JM. Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest. 2000;105:287-92.
9. Ek J, Urhammer SA, Sorensen TIA, Andersen T, Auwerx J, Pedersen O. Homozygosity of the Pro12Ala variant of the peroxisome proliferator activated receptor 2 (PPAR- 2): divergent modulating effects on body mass index in obese and lean men of Caucasian origin. Diabetologia. 1999;42:892-95.
10. Hegele RA, Cao H, Harris SB, Zinman B, Hanley AJ, Anderson CM. Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab. 2000;85:2014-9.
11. Lindi VI, Uusitupa MI, Lindstrom J, Louheranta A, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, et al. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes. 2002;51:2581-6.
12. Meirhaeghe A, Amouyel P. Impact of genetic variation of PPAR in humans. Mol Genet Metab. 2004;83:93-102.
13. Mancini FP, Vaccaro O, Sabatino L, Tufano A, Rivellese AA, Riccardi G, Colantuoni V. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes. 1999;48:1466-8.
14. Oh EY, Min KM, Chung JH, Min YK, Lee MS, Kim KW, Lee MK. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects. J Clin Endocrinol Metab. 2000;85:1801-4.
15. Hsueh WC, Cole SA, Shuldiner AR, Beamer BA, Blangero J, Hixson JE, MacCluer JW, Mitchell BD. Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferator-activated receptorgamma2 genes and obesity. Diabetes Care. 2001;24:672-77.
16. Luan J, Browne PO, Harding AH, Halsall DJ, O'Rahilly S, Chatterjee VK, Wareham NJ. Evidence for gene-nutrient interaction at the PPAR gamma locus. Diabetes. 2001;50:686-89.
17. Stefan N, Fritsche A, Haring HU, Stumvoli M. Effects of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene. Diabetes. 2001;50:1143-48.
18. Franks PW, Luan J, Browne PO, Harding AH, O'Rahilly S, Chatterjee VK, Wareham NJ. Does peroxisome proliferator-activated receptor gamma genotype (Pro12Ala) modify the association of physical activity and dietary fat with fasting insulin level? Metabolism. 2004;53:11-6.
19. Willett WC. Dietary fat plays a major role in obesity: no. Obes Rev. 2002;3:59-68.
20. Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, Sternbach DD, Lehmann JM, Wisely GB, et al. Molecular recognition of fatty acids by peroxisome proliferator activated receptors. Mol Cell. 1999;3:397-403.
21. Stumvoll M, Haring H. The peroxisome proliferator-activated receptor 2 Pro12Ala polymorphism. Diabetes. 2002;51:2341-7.
22. Robitaille J, Després JP, Pérusse L, Vohl MC. The PPAR gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study. Clin Genet. 2003;63:109-16.
23. Memisoglu A, Hu FB, Hankinson S, Manson J, De Vivo I, Willett WC, Hunter DJ. Interaction between a peroxisome proliferator-activated receptor gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet. 2003;12:2923-9.
24. Soriguer-Escofet F, Esteva I, Rojo-Martínez G, Ruiz de Adana S, Catalá M, Merelo MJ, Aguilar M, Tinahones F, García-Almeida JM, et al. Prevalence of diabetes mellitus type LADA in South Spain. Diabetes Res Clin Pract. 2002;56:213-20.
25. Soriguer F, Rojo-Martínez G, Dobarganes MC, Garcia Almeida JM, Esteva I, Beltran M, Ruiz De Adana MS, Tinahones F, Gómez-Zumaquero JM, et al. Hypertension is related to the degradation of dietary frying oils. Am J Clin Nutr. 2003;78:1092-7.
26. Instituto de Estadística de AndalucíaSistema de información municipal de Andalucía 1996. Junta de Andalucía, Sevilla.
27. Soriguer F, Rojo Martinez G, Esteva I, Ruiz De Adana MS, Catala M, Merelo MJ, Tinahones F, Cardona F, Dobarganes C, et al. Physical activity and cardiovascular and metabolic risk factors in general population. Med Clin (Barc). 2003;121:565-9.
28. Physical status: the use and interpretation of anthropometry.Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1-452.
29. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
30. Molarius A, Seidell JC. Selection of anthropometrics indicators for classification of abdominal fatness a critical review. Int J Obes Relat Metab Disord. 1998;22:719-27.
31. Soriguer F, Serna S, Valverde E, Hernando J, Martin-Reyes A, Soriguer M, Pareja A, Tinahones F, Esteva I. Lipid, protein and calorie content of different altlantic and mediterranean fish, shellfish and mollusks commonly eaten in the south of Spain. Eur J Epidemiol. 1997;13:451-63.
32. Hamilton S, Hamilton RJ, Sewell PA. Extraction of lipids and derivative formation. In: Hamilton & Hamilton, eds. Lipid analysis. A practical approach. Oxford: Oxford University Press 1992: p13-38.
33. IUPAC Standard Methods for the Analysis of Oils, Fats and Derivatives, 1st Supplement to the 7th Edition. International Union of Pure and Applied Chemistry, IUPAC (Ed), Pergamon Press, Oxford, England 1992.
34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
35. Queipo-Ortuño MI, Garcia-Ordónez MA, Colmenero JD, Morata P. Hydrogen peroxide improves the efficiency of a peripheral blood PCR assay for diagnosis of human brucellosis. Biotechniques. 1999;27:248-50.
36. Hara K, Okada T, Tobe K, Yasuda K, Mori Y, Kadowaki H, Hagura R, Akanuma Y, Kimura S, et al. The Pro12Ala Polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun. 2000;271:212-6.
37. Xu J, Turner A, Little J, Bleecker ER, Meyers DA. Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error? Hum Genet. 2002;111:573-4.
38. Masud S, Ye S. Effect of the peroxisome proliferator activated receptor gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet. 2003;40:773-80.
39. Douglas JA, Erdos MR, Watanabe RM, Braun A, Johnston CL, Oeth P, Mohlke KL, Valle TT, Ehnholm C, et al. The peroxisome proliferator activated receptor gamma Pro12Ala variant: association with type 2 diabetes and trait differences. Diabetes. 2001;50:886-90.
40. Mori H, Ikegami H, Kawaguchi Y, Seino S, Yokoi N, Takeda J, Inoue I, Seino Y, Yasuda K, et al. The Pro12 → Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes. 2001;50:891-4.
41. Walczak R, Tontonoz P. PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism. J Lipid Res. 2002;43:177-86.
42. Nicklas BJ, van Rossum EF, Berman DM, Ryan AS, Dennis KE, Shuldiner AR. Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes. 2001;50:2172-6.
43. Kesteloot H, Joosens JV. Nutrition and international patterns of disease. In Coronary Heart Disease Epidemiology. Marmot M, ed. Oxford University Press 1992: p152-165.
44. Serra-Majem L. Ngo de la Cruz J, Ribas L, Tur JA. Olive oil and the Mediterranean diet: beyond the rhetoric. Eur J Clin Nutr. 2003;57:Suppl 1:S2-7.
45. Rojo-Martínez G, Esteva I, Ruiz de Adana MS, Catalá M, Merelo MJ, Tinahones F, Gómez-Zumaquero JM, Cuesta AL, Cardona F, Soriguer F. Patterns of insulin resistance in the general population of southeast Spain. Diabetes Res Clin Pract. 2004;65:247-56.